 |
Chairman of the Board of Directors/Chief Strategy Officer Chiang Wei-feng Master of Business Administration, National Chung Hsing University ● Former General Manager of Han Ding Company in Taiwan ●Former Investment Director of Jardine Venture Capital Group and General Manager of Friends Capital Consulting Company ●Specializes in overall company operations management, with successful investments in IT, semiconductors, optoelectronics, communications, computer peripherals, passive components, electromechanical, automotive and motorcycle components, and biotechnology and pharmaceuticals. Expertise covers company management, industrial strategic alliances, domestic and international capital markets, and corporate mergers and reorganizations.
|
|
 |
CEO Jassy Wang, Ph.D. Ph.D. in Chemistry, Iowa State University ● Former Deputy Director of the Institute of Materials and Chemical Engineering, Industrial Technology Research Institute ● Former Convener of the Nano-Biomedical Field of the National Nanotechnology Program ● Led a team combining materials chemistry and biomedical engineering to carry out a nano-drug development plan. During this period, imaging agents and anti-cancer drug formulations were transferred to the industry, and INDs were assisted. He also served as a reviewer for a number of national nano-drug and medical device programs of the Ministry of Economic Affairs, the Ministry of Science and Technology, and the Ministry of Health and Welfare.
|
|
 |
President Yuan-Hung Hsu, Ph.D. Ph.D. in Chemical Engineering, National Chung Hsing University ● Former Deputy Manager of Drug Delivery Technology Department/Project of Biomedical Institute of Industrial Technology Research Institute ● Former project leader of the National Nano-Biomedical Program ● Specializes in nano new dosage form design, physical and chemical property testing, animal experiment design and related GMP compliance aseptic amplification process establishment. Successfully transferred anti-cancer drug nano micelle new dosage form to the industry and assisted in the planning of pre-clinical trials and sample production.
|
|
 |
Associate Director of Translational Science Greg Chen, Ph.D. Ph.D. in Microbiology and Immunology, National Cheng Kung University ● Former Project Deputy Manager of the Composite Materials Laboratory of the Biomedical Institute of Industrial Technology Research Institute ● Former adjunct lecturer in the Department of Medical Technology at China Medical University/Department of Nursing at Jinnan University of Pharmacy ●Specializes in the establishment of immunoanalytical methods/animal disease model establishment, and successfully developed a magnetic resonance nano-contrast agent for immune cell tracking, which can be used for early detection of organ transplant rejection and cancer cell lymph node metastasis detection.
|
|
 |
Vice President of Operations Center Mark Chiu Bachelor of Accounting, Tamkang University ● Former Manager of Yongjing Holdings Co., Ltd. ● Former Associate Manager of Efly.com International Travel Co., Ltd. ●Familiar with accounting, finance, stock affairs, board operations, IPO listing and other financial and accounting related fields.
|
|
 |
Director of Project Management and Regulation Office Zhong Hao Shi, Ph.D. Ph.D. in Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University ● Former Senior Manager, Regulatory Affairs, Foresee Pharmaceuticals ● Former Associate Director, Regulatory Affairs, United Biopharma ● With extensive experience spanning both regulatory authorities and the biopharmaceutical industry, Dr. Shi specializes in regulatory strategy throughout the entire drug development lifecycle. He has successfully led regulatory planning for multiple clinical development programs, facilitated cross-functional collaboration, and advanced project execution from development through regulatory submission.
|
|
 |
Director of Division of Product Development and Manufacturing Gavin Liu, Ph.D. Ph.D. in Pharmacy, Kaohsiung Medical University ● Former Director, Formulation Development Division, Lin Yang Biotechnology ● Former Supervising Pharmacist, China Chemical & Pharmaceutical Co., Ltd. ● Dr. Liu brings extensive expertise in injectable formulations, lyophilization technologies, and scale-up manufacturing processes. His experience includes targeted and controlled-release drug delivery systems, specialty pharmaceuticals, and the development of innovative pharmaceutical dosage forms from concept to commercialization.
|
|
 |
Manager of Project Management and Regulation Office Lexie Chien M.S. in Pharmaceutical Sciences, National Defense Medical Center ● Former Project Manager, Oneness Biotech Co., Ltd. ● Former Quality Assurance Manager, Apex Medical Corp. ● Mrs. Chien has extensive experience in quality management systems, regulatory compliance, and pharmaceutical project management. He has successfully supported companies in achieving ISO, GDP, and GMP certifications, while leading cross-functional initiatives that enhance operational excellence, development efficiency, and regulatory compliance.
|
